Related Experiment Video
Updated: Sep 28, 2025

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
Published on: May 11, 2016
A Novel External Auditory Canal Squamous Cell Carcinoma Cell Line Sensitive to CDK4/6 Inhibition
Rocío García-Marín1, Virginia N Cabal1, Carmen Fernández-Cedrón Bermejo2
1Department of Head and Neck Cancer, Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
Objective:
To characterize cell line CAE606 derived from a squamous cell carcinoma (SCC) of the external auditory canal (EAC) and to show its usefulness as a model for testing candidate therapeutic agents.
Study Design:
Preclinical translational research.
Setting:
Biomedical research institute.
Methods:
The cell line was initiated from a moderately differentiated T2N0M0 EAC SCC. We studied its histologic and genetic features as well as growth and invasion parameters. Sensitivity to cell CDK4/6 cell cycle inhibitor palbociclib was analyzed.
Results:
CAE606 cells expressed heavy molecular weight cytokeratin, p63, and vimentin. The population doubling time was 25.8 hours, and the cells showed fast collective cell migration in a wound-healing assay. Short tandem repeat analysis confirmed it to be derived from the primary tumor of the patient. Next-generation sequencing revealed alterations in cell cycle regulation genes, including inactivating mutations in CDKN2A and TP53 and high-level amplification of CCND1 and EGFR. CAE606 showed a strong decrease of phospo-Rb expression upon exposure to the CDK4/6 inhibitor palbociclib, causing significant growth inhibition with an IC50 of 0.46 µM.
Conclusion:
This is the first report of a stable EAC SCC cell line. Its genetic features make it a useful tool for preclinical testing of new therapeutic agents for EAC SCC, particularly those targeting cell cycle regulation in combination with radio- and chemotherapy or other specific signaling pathway inhibitors.
Insights
A new cell line, CAE606, derived from external auditory canal squamous cell carcinoma (EAC SCC) has been characterized. This model is useful for preclinical testing of targeted therapies for EAC SCC.
Area of Science:
- Oncology
- Cell Biology
- Genetics
Background:
- External auditory canal squamous cell carcinoma (EAC SCC) is a rare malignancy.
- Limited availability of well-characterized cell lines hinders EAC SCC research.
- Developing reliable preclinical models is crucial for advancing therapeutic strategies.
Purpose of the Study:
- To characterize a newly established cell line, CAE606, derived from EAC SCC.
- To evaluate the utility of CAE606 as a preclinical model for therapeutic agent testing.
- To investigate the genetic alterations and drug sensitivity of EAC SCC.
Main Methods:
- Histologic and genetic characterization of the CAE606 cell line.
- Assessment of cell growth, migration, and invasion parameters.
- Evaluation of sensitivity to the CDK4/6 inhibitor palbociclib.
Main Results:
- CAE606 cells exhibit characteristic SCC markers and genetic alterations in cell cycle regulation genes (CDKN2A, TP53, CCND1, EGFR).
- The cell line demonstrates rapid growth and migration, confirmed by wound-healing assays.
- CAE606 cells are sensitive to palbociclib, with significant growth inhibition observed.
Conclusions:
- CAE606 represents the first stable cell line for EAC SCC, providing a valuable preclinical research tool.
- Its genetic profile and drug sensitivity make it suitable for testing novel therapeutics targeting cell cycle pathways.
- This model can aid in developing combination therapies for EAC SCC, including those involving radiation and chemotherapy.
More Related Videos
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
06:11Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
Related Concept Videos
Inhibition of Cdk Activity
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...